Belvedere Trading LLC Gamida Cell Ltd. Call Options Transaction History

Belvedere Trading LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Jul 21, 2022	SELL	$1.73 - $4.29 $50,343 - $124,839	-29,100 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$2.22 - $4.47 $148,296 - $298,596	-66,800 Reduced 69.66%	29,100 $92,000
Q4 2021 Jan 25, 2022	BUY	$2.2 - $4.46 $210,980 - $427,714	95,900 New	95,900 $311,000
Q3 2021 Oct 19, 2021	SELL	$3.85 - $6.44 $142,835 - $238,924	-37,100 Closed	0 $0
Q2 2021 Jul 23, 2021	SELL	$5.85 - $8.33 $54,405 - $77,469	-9,300 Reduced 20.04%	37,100 $220,000

Q1 2021 Apr 27, 2021	BUY	$7.8 - $12.43 $361,920 - $576,752	46,400 New	46,400 $375,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.